Correction: Virtual Bioequivalence Assessment of Ritlecitinib Capsules with Incorporation of Observed Clinical Variability Using a Physiologically Based Pharmacokinetic Model
AAPS J
.
2024 Feb 21;26(2):27.
doi: 10.1208/s12248-024-00895-w.
Authors
Anas Saadeddin
1
,
Vivek Purohit
2
,
Yeamin Huh
2
,
Mei Wong
3
,
Aurelia Maulny
3
,
Martin E Dowty
4
,
Kazuko Sagawa
5
Affiliations
1
Pharmaceutical Science, Pfizer Worldwide Research and Development, Madrid, Spain.
2
Translational Clinical Science, Pfizer Worldwide Research and Development, Groton, Connecticut, USA.
3
Pharmaceutical Science, Pfizer Worldwide Research and Development, Sandwich, UK.
4
Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, USA.
5
Pharmaceutical Science, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, CT, 06340, USA.
[email protected]
.
PMID:
38383803
DOI:
10.1208/s12248-024-00895-w
No abstract available
Publication types
Published Erratum